Position in LNTH
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$7,539,926
+$1,056,724 QoQ
Shares Held
67,964
-20.5% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#87
of 466 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Stanley-Laman Group, Ltd. holds $12,165,674 across 2 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (62.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
This page
|
67,964 | $7,539,926 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
27,446 | $4,625,748 |
All Filings in LNTH
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,539,926 | 67,964 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,483,202 | 85,474 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $5,020,931 | 75,446 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,087,094 | 79,686 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,703,430 | 57,457 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $5,895,625 | 60,406 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $5,478,172 | 61,236 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $7,170,626 | 65,336 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $6,129,900 | 76,347 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,733,600 | 76,054 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,683,048 | 59,404 | Shares | Sole | 2024-02-02 | |
| No filing history on record for this holder in this stock. | ||||||